{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:35:50Z","timestamp":1785418550030,"version":"3.56.0"},"reference-count":49,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea, Oradea, Romania"},{"id":[{"id":"https:\/\/ror.org\/00wzhv093","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>(1) Background: Psoriasis is increasingly recognized as a systemic inflammatory disease associated with metabolic comorbidities. However, the hierarchical relationship between inflammatory activation and insulin resistance in driving metabolic syndrome (MetS) remains incompletely defined. This study aimed to characterize the integrated inflammatory\u2013metabolic architecture of psoriasis using multivariate and latent domain modeling. (2) Methods: In this cross-sectional hospital-based study (2020\u20132022), 235 adult patients with psoriasis were evaluated. Systemic inflammatory markers (NLR, SII, CRP, ESR) and composite metabolic indices (TyG, AIP, METS-IR) were assessed. Correlation analysis, multivariable linear and logistic regression, interaction modeling, and principal component analysis (PCA) were performed to examine independent associations and underlying domain structure. (3) Results: Inflammatory and metabolic markers showed modest but significant correlations. In multivariable logistic regression, the TyG index was the strongest independent predictor of MetS (OR = 5.15, p &lt; 0.001), whereas inflammatory markers did not retain independent significance. An interaction between adiposity and insulin resistance further improved model discrimination (AUC = 0.830). PCA identified two distinct latent domains explaining 69.9% of total variance: an immune\u2013inflammatory domain (NLR, SII, ESR, CRP) and a metabolic\u2013insulin resistance domain (TyG, AIP, METS-IR). Only the metabolic domain independently discriminated MetS. (4) Conclusions: Psoriasis exhibits a multidimensional systemic architecture characterized by partially independent inflammatory and metabolic domains. Although systemic inflammation and metabolic dysfunction coexist, insulin-resistance-related indices were more strongly associated with metabolic syndrome in this cohort.<\/jats:p>","DOI":"10.3390\/life16050821","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:33:54Z","timestamp":1779687234000},"page":"821","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Assessment of Inflammatory and Lipid\u2013Metabolic Biomarkers in Psoriasis: Implications for Metabolic Syndrome"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1684-3291","authenticated-orcid":false,"given":"Laura-Florina","family":"Nistor","sequence":"first","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3182-1683","authenticated-orcid":false,"given":"Ruxandra Cristina","family":"Marin","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Pharmacology, Clinical Pharmacology and Pharmacotherapy, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0296-6592","authenticated-orcid":false,"given":"Delia Mirela","family":"Tit","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela S.","family":"Bungau","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Radu","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-1958","authenticated-orcid":false,"given":"Timea Claudia","family":"Ghitea","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela Marioara","family":"Toma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Maria","family":"Endres","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Psycho-Neurosciences and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"adv42945","DOI":"10.2340\/actadv.v105.42945","article-title":"Epidemiology of Psoriasis: A Worldwide Global Study","volume":"105","author":"Skayem","year":"2025","journal-title":"Acta Derm. Venereol."},{"key":"ref_2","unstructured":"(2026, February 25). Global Psoriasis Atlas PHASE III Annual Report April 2024\u2013March 2025. Available online: https:\/\/www.globalpsoriasisatlas.org\/uploads\/attachments\/zsycmbmpb9u0a2l8x4mna3k2-gpa-annual-report-2024-2025.pdf."},{"key":"ref_3","first-page":"100007","article-title":"Viewing Psoriasis as a Systemic Disease for Better Health Outcomes","volume":"1","author":"Gondo","year":"2021","journal-title":"JID Innov. Ski. Sci. Mol. Popul. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10787-024-01602-z","article-title":"Naturally Derived Bioactive Compounds as Precision Modulators of Immune and Inflammatory Mechanisms in Psoriatic Conditions","volume":"33","author":"Radu","year":"2024","journal-title":"Inflammopharmacology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.abd.2021.10.007","article-title":"The Risk of Organ-Based Comorbidities in Psoriasis: A Systematic Review and Meta-Analysis","volume":"97","author":"Tang","year":"2022","journal-title":"An. Bras. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/tmi.14052","article-title":"Assessing Systemic Inflammatory Markers in Psoriasis: A Retrospective Study","volume":"29","author":"Solak","year":"2024","journal-title":"Trop. Med. Int. Health"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kimak-Pielas, A., Robak, E., Zajdel, R., and \u017bebrowska, A. (2025). The Relationship Between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index Markers and Response to Biological Therapy in Patients with Psoriasis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26083868"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00109-023-02406-4","article-title":"A Simple Tool for Evaluation of Inflammation in Psoriasis: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio as Markers in Psoriasis Patients and Related Murine Models of Psoriasis-like Skin Disease","volume":"102","author":"Kommoss","year":"2024","journal-title":"J. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/CM9.0000000000002504","article-title":"Research Progress of Metabolomics in Psoriasis","volume":"136","author":"Guo","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Coman, L.I., Balaban, D.V., Dumbrav\u0103, B.F., P\u0103unescu, H., Marin, R.-C., Costescu, M., Dima, L., Jinga, M., and Coman, O.A. (2025). Targeting Oxidative Stress in Acute Pancreatitis: A Critical Review of Antioxidant Strategies. Nutrients, 17.","DOI":"10.3390\/nu17152390"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard-2024-226150","article-title":"Psoriatic arthritis phenotype clusters and their association with treatment response: A real-world longitudinal cohort study from the psoriatic arthritis research consortium","volume":"84","author":"Karmacharya","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Balato, A., Zink, A., Babino, G., Buononato, D., Kiani, C., Eyerich, K., Ziehfreund, S., and Scala, E. (2022). The Impact of Psoriasis and Atopic Dermatitis on Quality of Life: A Literature Research on Biomarkers. Life, 12.","DOI":"10.3390\/life12122026"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e70050","DOI":"10.1002\/iid3.70050","article-title":"Association Between Systemic Immune-Inflammation Index and Psoriasis, Psoriasis Comorbidities, and All-Cause Mortality: A Study Based on NHANES","volume":"12","author":"Zhao","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Huang, D., Ma, R., Zhong, X., Jiang, Y., Lu, J., Li, Y., and Shi, Y. (2023). Positive Association between Different Triglyceride Glucose Index-Related Indicators and Psoriasis: Evidence from NHANES. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1325557"},{"key":"ref_16","first-page":"215","article-title":"Metabolic Syndrome in Psoriasis Patients-an Observational Study","volume":"50","author":"Dinescu","year":"2024","journal-title":"Curr. Health Sci. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.det.2024.02.008","article-title":"Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis","volume":"42","author":"Song","year":"2024","journal-title":"Dermatol. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.jid.2023.03.1655","article-title":"Regional Variation in Cardiovascular Risk Factor Screening by Dermatologists for Psoriasis Patients in the United States","volume":"143","author":"Song","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"And\u00fajar, I., Esplugues, J.V., and Garc\u00eda-Mart\u00ednez, P. (2022). Looking beyond the Skin: Pathophysiology of Cardiovascular Comorbidity in Psoriasis and the Protective Role of Biologics. Pharmaceuticals, 15.","DOI":"10.3390\/ph15091101"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/PTT.S320016","article-title":"Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health","volume":"11","author":"Teklu","year":"2021","journal-title":"Psoriasis Targets Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Anyfanti, P., Margouta, A., Goulas, K., Gavriilaki, M., Lazaridou, E., Patsatsi, A., and Gkaliagkousi, E. (2022). Endothelial Dysfunction in Psoriasis: An Updated Review. Front. Med., 9.","DOI":"10.3389\/fmed.2022.864185"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5937\/jomb0-45076","article-title":"Oxidative Stress and Metabolic Biomarkers in Patients with Psoriasis","volume":"43","year":"2024","journal-title":"J. Med. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kirichenko, T.V., Markina, Y.V., Bogatyreva, A.I., Tolstik, T.V., Varaeva, Y.R., and Starodubova, A.V. (2022). The Role of Adipokines in Inflammatory Mechanisms of Obesity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314982"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-3-031-63657-8_14","article-title":"Insulin Resistance, Obesity, and Lipotoxicity","volume":"Volume 1460","author":"Engin","year":"2024","journal-title":"Obesity and Lipotoxicity"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhao, X., An, X., Yang, C., Sun, W., Ji, H., and Lian, F. (2023). The Crucial Role and Mechanism of Insulin Resistance in Metabolic Disease. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1149239"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"111162","DOI":"10.4252\/wjsc.v17.i11.111162","article-title":"Targeting Adipose Remodeling: Synergistic Mechanisms of Drugs and Adipose-Derived Stem Cells in Obese Type 2 Diabetes Mellitus","volume":"17","author":"Luo","year":"2025","journal-title":"World J. Stem Cells"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e142534","DOI":"10.1172\/jci.insight.142534","article-title":"Chronic Inflammation in Psoriasis Promotes Visceral Adiposity Associated with Noncalcified Coronary Burden over Time","volume":"5","author":"Sajja","year":"2020","journal-title":"JCI Insight"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"S\u0142uczanowska-G\u0142abowska, S., Staniszewska, M., Marchlewicz, M., Duchnik, E., \u0141uczkowska, K., Safranow, K., Machali\u0144ski, B., and Pawlik, A. (2023). Adiponectin, Leptin and Resistin in Patients with Psoriasis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12020663"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hao, Y., Zhu, Y.-J., Zou, S., Zhou, P., Hu, Y.-W., Zhao, Q.-X., Gu, L.-N., Zhang, H.-Z., Wang, Z., and Li, J. (2021). Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.711060"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, Y., Huang, D., Ma, B., Jiang, Y., Yu, B., Zheng, J., Ding, Y., and Shi, Y. (2025). Positive Associations between Triglyceride-Glucose (TyG) and TyG-Body Mass Index (TyG-BMI) with Cardiovascular Disease in Patients with Psoriasis: Cross-Sectional Results from the SPEECH. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1644887"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13098-024-01423-8","article-title":"The Triglyceride-Glucose Index Is a Predictor of Major Adverse Cardiovascular Events in Patients with Coronary Artery Disease and Psoriasis: A Retrospective Cohort Study","volume":"16","author":"Fu","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jaad.2022.08.027","article-title":"Association of the Triglyceride Glucose Index with Insulin Resistance and Subclinical Atherosclerosis in Psoriasis: An Observational Cohort Study","volume":"88","author":"Patel","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"26123","DOI":"10.1038\/s41598-024-77784-x","article-title":"Association of METS-IR Index with Psoriasis in US Adults: A Cross-Sectional Study","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhong, X., Huang, D., Chen, R., Yao, L., Ma, R., Yu, Y., Jiang, Y., Kong, L., Lu, J., and Li, Y. (2024). Positive Association between Insulin Resistance and Fatty Liver Disease in Psoriasis: Evidence from a Cross-Sectional Study. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1388967"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4103\/ijd.ijd_167_24","article-title":"Biomarkers in Psoriasis: The Future of Personalised Treatment","volume":"69","author":"Kar","year":"2024","journal-title":"Indian J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e077596","DOI":"10.1136\/bmjopen-2023-077596","article-title":"Association between the Neutrophil-to-Lymphocyte Ratio and Psoriasis: A Cross-Sectional Study of the National Health and Nutrition Examination Survey 2011\u20132014","volume":"13","author":"Hong","year":"2023","journal-title":"BMJ Open"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00403-024-03403-4","article-title":"Residual Metabolic Burden in Young Psoriasis Patients Successfully Treated with Biologics","volume":"316","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_39","first-page":"11275","article-title":"Triglyceride Glucose Index: A Novel Biomarker in the Management of Patients with Psoriasis","volume":"27","author":"Tamer","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Buonacera, A., Stancanelli, B., Colaci, M., and Malatino, L. (2022). Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073636"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"104598","DOI":"10.1016\/j.mvr.2023.104598","article-title":"Neutrophil-to-Lymphocyte Ratio an Inflammatory Biomarker, and Prognostic Marker in Heart Failure, Cardiovascular Disease and Chronic Inflammatory Diseases: New Insights for a Potential Predictor of Anti-Cytokine Therapy Responsiveness","volume":"150","author":"Galeote","year":"2023","journal-title":"Microvasc. Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Yontar, G., and Mutlu, E.A. (2024). Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte Ratios and Systemic Immune-Inflammation Index in Patients with Post-Traumatic Stress Disorder. BMC Psychiatry, 24.","DOI":"10.1186\/s12888-024-06439-y"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wei, Y., Wang, T., Li, G., Feng, J., Deng, L., Xu, H., Yin, L., Ma, J., Chen, D., and Chen, J. (2022). Investigation of Systemic Immune-Inflammation Index, Neutrophil\/High-Density Lipoprotein Ratio, Lymphocyte\/High-Density Lipoprotein Ratio, and Monocyte\/High-Density Lipoprotein Ratio as Indicators of Inflammation in Patients with Schizophrenia and Bipola. Front. Psychiatry, 13.","DOI":"10.3389\/fpsyt.2022.941728"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lioy, B., Webb, R.J., and Amirabdollahian, F. (2023). The Association between the Atherogenic Index of Plasma and Cardiometabolic Risk Factors: A Review. Healthcare, 11.","DOI":"10.3390\/healthcare11070966"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.advms.2021.09.003","article-title":"The Predictive Value of Atherogenic Index of Plasma in the Prediction of Cardiovascular Events; a Fifteen-Year Cohort Study","volume":"66","author":"Sadeghi","year":"2021","journal-title":"Adv. Med. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Qiu, J., He, S., Yu, C., Yang, R., Kuang, M., Sheng, G., and Zou, Y. (2024). Assessing the Validity of METS-IR for Predicting the Future Onset of Diabetes: An Analysis Using Time-Dependent Receiver Operating Characteristics. BMC Endocr. Disord., 24.","DOI":"10.1186\/s12902-024-01769-0"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"132663","DOI":"10.1016\/j.ijcard.2024.132663","article-title":"Triglyceride-Glucose Index (TyG) as a Novel Biomarker in the Era of Cardiometabolic Medicine","volume":"418","author":"Avagimyan","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Aznar-Esquivel, A., G\u00f3mez-Bernal, F., Garc\u00eda-Gonz\u00e1lez, M., Hern\u00e1ndez-Diaz, M., Heras-Recuero, E., de Vera-Gonz\u00e1lez, A., Gonz\u00e1lez-Delgado, A., Quevedo-Rodr\u00edguez, A., Quevedo-Abeledo, J.C., and Casta\u00f1eda, S. (2025). The Metabolic Score for Insulin Resistance (METS-IR), a Predictor of Cardiovascular Events, Relates to Disease Activity in Patients with Rheumatoid Arthritis. Diagnostics, 15.","DOI":"10.3390\/diagnostics15070861"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and Management of the Metabolic Syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/5\/821\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:51:12Z","timestamp":1779688272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/5\/821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["life16050821"],"URL":"https:\/\/doi.org\/10.3390\/life16050821","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]}}}